Ready to contact us for a consultation about your condition and our medical services? The staff of our Global Patient Services is ready to help. Please select the appropriate button to get started.

Sheba Signs Historic Collaboration Agreements With Two Bahraini Hospitals

Meeting between the two Bahraini Hospitals Agreement with Sheba
“This is a historic opportunity to establish meaningful relations with the Kingdom of Bahrain.”

With the signing of the Abraham Accords in 2020, Israel and Bahrain normalized their relations, which opened up many new possibilities.

The Bahrain Supreme Council of Health recently chose Sheba Medical Center to lead medical cooperation between the two countries. Subsequently, groundbreaking medical collaboration agreements were reached with two large hospitals in Bahrain: Salmaniya Medical Complex and King Hamad University Hospital.

According to Sheba Global Director, Yoel Hareven, who led the Sheba delegation sent to Bahrain to sign the landmark accords: “This is a historic opportunity to establish meaningful relations with the Kingdom of Bahrain. The cooperation with the Bahraini healthcare sector will expand in the next months to include medical care, mainly via Sheba’s virtual hospital, Sheba Beyond, as well as medical staff training, joint research projects, and more.”


Ayelet’s Miracle: The First Woman to Conceive Four Children Following Ovarian Tissue Cryopreservation

At 21, Ayelet Rozenberg was diagnosed with Hodgkin’s lymphoma. Facing aggressive therapies necessary to save her life, Ayelet feared she would never be able to…
Read More
bowel disease
News Sep 07.

Sheba Partners with Biomica to Advance Inflammatory Bowel Disease Care

As part of the new collaboration, Sheba and Biomica will engage in joint microbiome clinical research to develop better treatments for inflammatory bowel disease (IBD)…
Read More
Hemophilia research
News Sep 05.

New Sheba Study Indicates: Novel Treatment Sharply Reduces Bleed Rates Among Hemophilia Patients

Results indicate that a monthly treatment with Fitusiran significantly reduces bleed rates among both hemophilia A and B patients.
Read More